Evolent names Shawn Guertin as new independent nominee for election to its Board of Directors

Core Viewpoint - Evolent Health, Inc. has nominated Mr. Shawn Guertin for election to its Board of Directors, reflecting the company's ongoing efforts to refresh its board and enhance corporate governance practices [1][2][3] Company Overview - Evolent Health specializes in improving health outcomes for individuals with complex conditions through innovative solutions that simplify and reduce the cost of healthcare [7] - The company serves a national base of leading payers and providers and is recognized as a top workplace in the healthcare sector [7] Board of Directors - Mr. Shawn Guertin, with nearly 40 years of experience in the insurance and healthcare sectors, has been recommended for election to the Board [2] - His previous roles include Executive Vice President and Chief Financial Officer at CVS Health Corporation and various leadership positions at Aetna and Coventry Health Care [6] - If elected, Mr. Guertin will replace Diane Holder, who has served on the board for 14 years and is not seeking re-election [4][5] Board Refreshment - Mr. Guertin's nomination marks the sixth new independent director added to the Board in the past four years, indicating a commitment to aligning corporate governance with best practices [3][8] - The Board's Nominating and Governance Committee conducted a search process to identify suitable candidates for the independent director position [2]